Biogen Eisai's Leqembi Alzheimer's drug rejected by EU regulator
European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…
health care industry
Bristol Myers Squibb (BMY) Q2 2024 Results
Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman |…
Fund manager of names in weight loss and biotechnology
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…
Dexcom shares fall more than 30% after the company lowered its fiscal year forecasts
The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket…
Viking Therapeutics shares rise on plans to test weight-loss injection
Weight loss drug concept. Cr | Istock | Getty Images Actions of Viking Therapeutics rose more than 20% on Thursday…
GE HealthCare taps Amazon Web Services to develop generative AI for medical use
Jakub Porzycki | Nurphoto | Getty Images GE Healthcare On Thursday he announced that he will partner with Amazon Web…
What you need to know as India issues alert
Fruit bats hanging from tree branches in daylight. Bats are believed to be one of the carriers of the Nipah…
Pfizer's gene therapy for hemophilia A successfully passes late-stage trials
Kena Betancur | Corbis News | Getty Images Pfizer On Wednesday, the US drugmaker announced that its experimental gene therapy…
First round of Medicare drug price negotiations nearing end
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Novo Nordisk's Wegovy gets UK approval for use in reducing heart risks
Novo Nordisk's Wegovy weight loss drug has experienced a meteoric rise in popularity. Nurphoto | Getty Images LONDON — The…